Ebru Güçlü

10PUBLICATIONS
18CO-AUTHORS
Cellular nervous systemChemotherapyPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Systems pharmacology and targeted transcriptional profiling suggest the putative neuroprotective role of Leuconostoc mesenteroides in an in vitro Alzheimer's disease model.

|May 04, 2026
The Effect of Cannabidiol on Cancer-Pathway Genes in Doxorubicin-Sensitive and Resistant Breast Cancer Cells.

|Nov 17, 2025
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.

Ebru Guclu, Salim Yalcin Inan, Canan Eroglu Gunes

|Apr 11, 2025
A sesquiterpene lactone, tomentosin, as a novel anticancer agent: orchestrating apoptosis, autophagy, and ER stress in colorectal cancer.

Sümeyra Çetinkaya, Ebru Güçlü, İlknur Çınar Ayan

|Jul 15, 2024
Piceatannol induces caspase-dependent apoptosis by modulating intracellular reactive oxygen species/mitochondrial membrane potential and enhances autophagy in neuroblastoma cells.

Ebru Güçlü, İlknur Çınar Ayan, Sümeyra Çetinkaya

|May 16, 2024
Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.

Safaa Altves, Ebru Guclu, Esra Yetisgin

Pageof 2

Frequent Collaborators

7 joint publications

Hasibe Vural

4 joint publications

İlknur Çınar Ayan

3 joint publications

Hatice Gül Dursun

3 joint publications

Safaa Altves